You are here

Launching of COSEQUIN® HA in Italy

22 Aug 2011
Companion Animal Health

COSEQUIN®’ HA revolutionary formula is now available in Italy thanks to BIOIBERICA’s exclusive distributor in Italy, CANDIOLI Farmaceutici, which presented COSEQUIN® HA at the 69th Edition of the SCIVAC International Congress held in Rimini (Italy) on May 27-29, 2011

COSEQUIN® HA includes the Hyal-Joint® DS molecule in its composition along with high purity chondroitin sulphate and Glucosamine HC1. Thanks to its contents in hyaluronic acid, Hyal-Join® DS increases the natural synthesis of hyaluronic acid and the maintenance of proper levels of synovial liquid, an element essential to improve joint mobility.  


All attendants who visited the CANDIOLI’s stand during the SCIVAC international congress were given information about the product. the people at CANDIOLI’s stand, whose motto was “All joints under control”, gave all visitors ample information about the new product’s characteristics. With this new formula, COSEQUIN® HA aims to position itself as the chondroprotection product of choice, as it gives a complete support to all structures affected by osteoarthritis: joint cartilage, subchondral bone, and synovial membrane.

Related News

27 May 2020
Companion Animal Health
  • This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
  • The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®
7 Apr 2020
Companion Animal Health
  • The study, carried out at the University of Florida, supports the use of this new formulation of sphingolipids and glycosaminoglycans as a strategy to improve skin health in patients with canine atopic dermatitis
5 Mar 2020
Companion Animal Health
  • The fourth Iberzoo Propet will be held from 5 to 7 March at the Feria de Madrid
  • Klorexivet®, Prolivet® and Condrovet Force HA® are scientifically proven products that bring value added for veterinarians